Claesen, K.; Mertens, J.C.; Leenaerts, D.; Hendriks, D.
Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery? Int. J. Mol. Sci. 2021, 22, 883.
https://doi.org/10.3390/ijms22020883
AMA Style
Claesen K, Mertens JC, Leenaerts D, Hendriks D.
Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery? International Journal of Molecular Sciences. 2021; 22(2):883.
https://doi.org/10.3390/ijms22020883
Chicago/Turabian Style
Claesen, Karen, Joachim C. Mertens, Dorien Leenaerts, and Dirk Hendriks.
2021. "Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?" International Journal of Molecular Sciences 22, no. 2: 883.
https://doi.org/10.3390/ijms22020883
APA Style
Claesen, K., Mertens, J. C., Leenaerts, D., & Hendriks, D.
(2021). Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery? International Journal of Molecular Sciences, 22(2), 883.
https://doi.org/10.3390/ijms22020883